Heart artery health after chest radiation using PET scan
Part of Heart & circulation clinical trials.
This study looks at how radiation therapy to the chest affects the arteries in your heart. It uses a special PET scan (with a safe radioactive tracer) to check for early signs of inflammation or plaque buildup, which can help doctors find ways to protect your heart during cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have stage II, III, or limited stage IV cancer (any type).
- You are scheduled to receive radiation therapy to your chest area (at least 30 Gy) that will include some of your heart.
- You are able to lie still on your back inside a scanner for about 30-60 minutes.
- You do not have severe kidney disease or a known allergy to contrast dye or the radioactive tracer used in this study.
- You do not have any metal implants, pacemakers, or claustrophobia that would prevent an MRI or PET scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of radioactive tracers used during heart PET scans to see if one is better at detecting blocked arteries. Participation involves receiving one of the tracers during your routine scan and may help improve heart disease diagnosis.
This trial studies how a specialized heart imaging test (PET/MPI) changes during the start of chemotherapy for cancer patients. It may help researchers understand whether this monitoring approach detects heart strain early and keeps patients safer during treatment.
This study uses special PET/MR imaging before and after radiation treatment to better understand how radiation may affect the heart and lungs. It may help researchers find ways to predict and monitor these side effects using imaging and blood tests.
This study looks at whether PET-CT scans can help detect heart damage caused by radiation therapy in patients with stage III lung cancer. If you're getting chemotherapy and radiation together, you may participate to help doctors find ways to reduce heart risks.
This study uses a special scan (PET/CT) to look for early heart (cardiac) injury caused by radiation treatment for lung or esophageal cancer. If you may be at higher heart risk from your planned radiation dose, the scan may help researchers better measure that damage over time.
This trial looks at how radiation for lung, esophageal, or breast cancer affects the heart. It may help doctors reduce heart damage in future patients.
Hear when a new Oligometastatic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.